BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Teng S, Zhang Y, Zhang W, Zhang X, Xu K, Yao H, Yao J, Wang H, Liang X, Hu Z. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT. Oncotarget 2017;8:47052-63. [PMID: 28423362 DOI: 10.18632/oncotarget.16789] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Švec J, Šťastná M, Janečková L, Hrčkulák D, Vojtěchová M, Onhajzer J, Kříž V, Galušková K, Šloncová E, Kubovčiak J, Pfeiferová L, Hrudka J, Matěj R, Waldauf P, Havlůj L, Kolář M, Kořínek V. TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness. Cancers 2022;14:4137. [DOI: 10.3390/cancers14174137] [Reference Citation Analysis]
2 Huebner K, Erlenbach-Wuensch K, Prochazka J, Sheraj I, Hampel C, Mrazkova B, Michalcikova T, Tureckova J, Iatsiuk V, Weissmann A, Ferrazzi F, Kunze P, Nalli E, Sammer E, Gehring A, Cheema MM, Eckstein M, Paap EM, Soederberg A, Fischer C, Paul S, Mahadevan V, Ndreshkjana B, Meier MA, Muehlich S, Geppert CI, Merkel S, Grutzmann R, Roehe A, Banerjee S, Hartmann A, Sedlacek R, Schneider-Stock R. ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2. Cell Mol Life Sci 2022;79:423. [PMID: 35838828 DOI: 10.1007/s00018-022-04445-5] [Reference Citation Analysis]
3 Vidula N, Yau C, Rugo H. Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer. Breast Cancer Res Treat 2022. [PMID: 35789445 DOI: 10.1007/s10549-022-06660-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lenárt S, Lenárt P, Knopfová L, Kotasová H, Pelková V, Sedláková V, Vacek O, Pokludová J, Čan V, Šmarda J, Souček K, Hampl A, Beneš P. TACSTD2 upregulation is an early reaction to lung infection. Sci Rep 2022;12:9583. [PMID: 35688908 DOI: 10.1038/s41598-022-13637-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ito T, Hashimoto H, Tanaka Y, Tanegashima K, Murata M, Ichiki T, Iwasaki T, Oda Y, Kaku-ito Y. TROP2 Expression in Sebaceous and Sweat Gland Carcinoma. JCM 2022;11:607. [DOI: 10.3390/jcm11030607] [Reference Citation Analysis]
6 Kamble PR, Patkar SR, Breed AA, Pathak BR. N-glycosylation status of Trop2 impacts its surface density, interaction with claudin-7 and exosomal release. Arch Biochem Biophys 2021;714:109084. [PMID: 34774484 DOI: 10.1016/j.abb.2021.109084] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Pavone G, Motta L, Martorana F, Motta G, Vigneri P. A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors. Molecules 2021;26:7294. [PMID: 34885875 DOI: 10.3390/molecules26237294] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Qi Y, Mo K, Zhang T. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms. Biomed Eng Online 2021;20:83. [PMID: 34399777 DOI: 10.1186/s12938-021-00919-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Ito T, Tanegashima K, Tanaka Y, Hashimoto H, Murata M, Oda Y, Kaku-Ito Y. Trop2 Expression in Extramammary Paget's Disease and Normal Skin. Int J Mol Sci 2021;22:7706. [PMID: 34299325 DOI: 10.3390/ijms22147706] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Wang Z, Jia L, Sun Y, Li C, Zhang L, Wang X, Chen H. CORO1C is Associated With Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer. Front Mol Biosci 2021;8:682594. [PMID: 34179087 DOI: 10.3389/fmolb.2021.682594] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
11 Swaminathan G, Shigna A, Kumar A, Byroju VV, Durgempudi VR, Dinesh Kumar L. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics. Front Nanotechnol 2021;3:694838. [DOI: 10.3389/fnano.2021.694838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Farag AGA, El-Rebey HS, El-Moneim Shoeib MA, Ahmed El-Fiky SM, Elshaib ME, Mostafa AF. The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study. Clin Cosmet Investig Dermatol 2021;14:591-600. [PMID: 34103959 DOI: 10.2147/CCID.S299862] [Reference Citation Analysis]
13 Zheng WP, Huang FY, Dai SZ, Wang JY, Lin YY, Sun Y, Tan GH, Huang YH. Toxicarioside O Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition by Downregulation of Trop2 in Lung Cancer Cells. Front Oncol 2020;10:609275. [PMID: 33614493 DOI: 10.3389/fonc.2020.609275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ma J, Qi J, Li S, Zhang C, Wang H, Shao L, Yuan X, Sha Q. Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer. Technol Cancer Res Treat 2020;19:1533033820926591. [PMID: 32406319 DOI: 10.1177/1533033820926591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Saffar H, Jahanbin B, Ameli F, Farhang F, Tavangar SM, Saffar H. Diagnostic Value of TROP2 Expression in Papillary Thyroid Carcinoma. Appl Immunohistochem Mol Morphol 2021;29:218-22. [PMID: 33264108 DOI: 10.1097/PAI.0000000000000886] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Lenárt S, Lenárt P, Šmarda J, Remšík J, Souček K, Beneš P. Trop2: Jack of All Trades, Master of None. Cancers (Basel) 2020;12:E3328. [PMID: 33187148 DOI: 10.3390/cancers12113328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
17 Fagotto F, Aslemarz A. EpCAM cellular functions in adhesion and migration, and potential impact on invasion: A critical review. Biochim Biophys Acta Rev Cancer 2020;1874:188436. [PMID: 32976980 DOI: 10.1016/j.bbcan.2020.188436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
18 Kamble PR, Rane S, Breed AA, Joseph S, Mahale SD, Pathak BR. Proteolytic cleavage of Trop2 at Arg87 is mediated by matriptase and regulated by Val194. FEBS Lett 2020;594:3156-69. [PMID: 32761920 DOI: 10.1002/1873-3468.13899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhang B, Gao S, Li R, Li Y, Cao R, Cheng J, Guo Y, Wang E, Huang Y, Zhang K. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation. BMC Cancer 2020;20:815. [PMID: 32854652 DOI: 10.1186/s12885-020-07257-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Hao Y, Zhang D, Guo Y, Fu Z, Yu D, Guan G. miR-488-3p sponged by circ-0000495 and mediated upregulation of TROP2 in head and neck squamous cell carcinoma development. J Cancer 2020;11:3375-86. [PMID: 32231744 DOI: 10.7150/jca.40339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Sun X, Xing G, Zhang C, Lu K, Wang Y, He X. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway. Cell Biochem Funct 2020;38:141-8. [PMID: 31967350 DOI: 10.1002/cbf.3450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
22 Kuai X, Jia L, Yang T, Huang X, Zhao W, Zhang M, Chen Y, Zhu J, Feng Z, Tang Q. Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells. Med Sci Monit 2020;26:e919566. [PMID: 31964857 DOI: 10.12659/MSM.919566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Steinmann S, Kunze P, Hampel C, Eckstein M, Bertram Bramsen J, Muenzner JK, Carlé B, Ndreshkjana B, Kemenes S, Gasparini P, Friedrich O, Andersen C, Geppert C, Wang S, Eyupoglu I, Bäuerle T, Hartmann A, Schneider-Stock R. DAPK1 loss triggers tumor invasion in colorectal tumor cells. Cell Death Dis 2019;10:895. [PMID: 31772156 DOI: 10.1038/s41419-019-2122-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
24 Tang G, Tang Q, Jia L, Chen Y, Lin L, Kuai X, Gong A, Feng Z. TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway. Int J Mol Med 2019;44:2161-70. [PMID: 31638186 DOI: 10.3892/ijmm.2019.4378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
25 Jiang S, Wang H, Guo Y, Liu Z, Song W. Acetylshikonin inhibits the migration and invasion of A375 cells by reversing EMT process via the PI3K/Akt/mTOR pathway. Biotechnology & Biotechnological Equipment 2019;33:699-706. [DOI: 10.1080/13102818.2019.1612277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Deng XT, Tang SM, Wu PY, Li QP, Ge XX, Xu BM, Wang HS, Miao L. SP/NK-1R promotes gallbladder cancer cell proliferation and migration. J Cell Mol Med 2019;23:7961-73. [PMID: 30903649 DOI: 10.1111/jcmm.14230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
27 Liu J, Yang D, Yin Z, Gao M, Tong H, Su Y, Zhu J, Ye C, Zhang H. A novel human monoclonal Trop2-IgG antibody inhibits ovarian cancer growth in vitro and in vivo. Biochem Biophys Res Commun 2019;512:276-82. [PMID: 30879767 DOI: 10.1016/j.bbrc.2019.03.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
28 Zhang J, Ma H, Yang L, Yang H, He Z. Silencing of the TROP2 gene suppresses proliferation and invasion of hepatocellular carcinoma HepG2 cells. J Int Med Res 2019;47:1319-29. [PMID: 30678511 DOI: 10.1177/0300060518822913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Shi M, Duan G, Nie S, Shen S, Zou X. Elevated FAM3C promotes cell epithelial- mesenchymal transition and cell migration in gastric cancer. Onco Targets Ther 2018;11:8491-505. [PMID: 30584315 DOI: 10.2147/OTT.S178455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
30 Kaavya J, Mahalaxmi I, Devi SM, Santhy KS, Balachandar V. Targeting phosphoinositide-3-kinase pathway in biliary tract cancers: A remedial route? J Cell Physiol 2019;234:8259-73. [PMID: 30370571 DOI: 10.1002/jcp.27673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Mehrotra R, Tulsyan S, Hussain S, Mittal B, Singh Saluja S, Singh S, Tanwar P, Khan A, Javle M, Hassan MM, Pant S, De Aretxabala X, Sirohi B, Rajaraman P, Kaur T, Rath GK. Genetic landscape of gallbladder cancer: Global overview. Mutat Res. 2018;778:61-71. [PMID: 30454684 DOI: 10.1016/j.mrrev.2018.08.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
32 Tang G, Tang Q, Jia L, Xia S, Li J, Chen Y, Li H, Ding X, Wang F, Hou D, Kuai X, Feng Z, Fan Y. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma. Pathol Res Pract 2018;214:1606-12. [PMID: 30098828 DOI: 10.1016/j.prp.2018.07.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
33 Li T, Su Y, Yu X, Mouniir DSA, Masau JF, Wei X, Yang J. Trop2 Guarantees Cardioprotective Effects of Cortical Bone-Derived Stem Cells on Myocardial Ischemia/Reperfusion Injury. Cell Transplant 2018;27:1256-68. [PMID: 30008230 DOI: 10.1177/0963689718786882] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
34 Goldenberg DM, Stein R, Sharkey RM. The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target. Oncotarget 2018;9:28989-9006. [PMID: 29989029 DOI: 10.18632/oncotarget.25615] [Cited by in Crossref: 49] [Cited by in F6Publishing: 85] [Article Influence: 12.3] [Reference Citation Analysis]
35 Zhang L, Yang G, Zhang R, Dong L, Chen H, Bo J, Xue W, Huang Y. Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells. Int J Oncol 2018;53:515-26. [PMID: 29901071 DOI: 10.3892/ijo.2018.4423] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
36 Sun YS. Studying Electrotaxis in Microfluidic Devices. Sensors (Basel) 2017;17:E2048. [PMID: 28880251 DOI: 10.3390/s17092048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
37 Cheng N, Li H, Luo J. Trop2 promotes proliferation, invasion and EMT of nasopharyngeal carcinoma cells through the NF-κB pathway. RSC Adv 2017;7:53087-96. [DOI: 10.1039/c7ra09915k] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]